1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Extracorporeal Circulation Supporting Intubation Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Extracorporeal Circulation Supporting Intubation by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Extracorporeal Circulation Supporting Intubation by Country/Region, 2018, 2022 & 2029
2.2 Extracorporeal Circulation Supporting Intubation Segment by Type
2.2.1 Adult Intubation
2.2.2 Pediatric Intubation
2.3 Extracorporeal Circulation Supporting Intubation Sales by Type
2.3.1 Global Extracorporeal Circulation Supporting Intubation Sales Market Share by Type (2018-2023)
2.3.2 Global Extracorporeal Circulation Supporting Intubation Revenue and Market Share by Type (2018-2023)
2.3.3 Global Extracorporeal Circulation Supporting Intubation Sale Price by Type (2018-2023)
2.4 Extracorporeal Circulation Supporting Intubation Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Extracorporeal Circulation Supporting Intubation Sales by Application
2.5.1 Global Extracorporeal Circulation Supporting Intubation Sale Market Share by Application (2018-2023)
2.5.2 Global Extracorporeal Circulation Supporting Intubation Revenue and Market Share by Application (2018-2023)
2.5.3 Global Extracorporeal Circulation Supporting Intubation Sale Price by Application (2018-2023)
3 Global Extracorporeal Circulation Supporting Intubation by Company
3.1 Global Extracorporeal Circulation Supporting Intubation Breakdown Data by Company
3.1.1 Global Extracorporeal Circulation Supporting Intubation Annual Sales by Company (2018-2023)
3.1.2 Global Extracorporeal Circulation Supporting Intubation Sales Market Share by Company (2018-2023)
3.2 Global Extracorporeal Circulation Supporting Intubation Annual Revenue by Company (2018-2023)
3.2.1 Global Extracorporeal Circulation Supporting Intubation Revenue by Company (2018-2023)
3.2.2 Global Extracorporeal Circulation Supporting Intubation Revenue Market Share by Company (2018-2023)
3.3 Global Extracorporeal Circulation Supporting Intubation Sale Price by Company
3.4 Key Manufacturers Extracorporeal Circulation Supporting Intubation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Extracorporeal Circulation Supporting Intubation Product Location Distribution
3.4.2 Players Extracorporeal Circulation Supporting Intubation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Extracorporeal Circulation Supporting Intubation by Geographic Region
4.1 World Historic Extracorporeal Circulation Supporting Intubation Market Size by Geographic Region (2018-2023)
4.1.1 Global Extracorporeal Circulation Supporting Intubation Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Extracorporeal Circulation Supporting Intubation Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Extracorporeal Circulation Supporting Intubation Market Size by Country/Region (2018-2023)
4.2.1 Global Extracorporeal Circulation Supporting Intubation Annual Sales by Country/Region (2018-2023)
4.2.2 Global Extracorporeal Circulation Supporting Intubation Annual Revenue by Country/Region (2018-2023)
4.3 Americas Extracorporeal Circulation Supporting Intubation Sales Growth
4.4 APAC Extracorporeal Circulation Supporting Intubation Sales Growth
4.5 Europe Extracorporeal Circulation Supporting Intubation Sales Growth
4.6 Middle East & Africa Extracorporeal Circulation Supporting Intubation Sales Growth
5 Americas
5.1 Americas Extracorporeal Circulation Supporting Intubation Sales by Country
5.1.1 Americas Extracorporeal Circulation Supporting Intubation Sales by Country (2018-2023)
5.1.2 Americas Extracorporeal Circulation Supporting Intubation Revenue by Country (2018-2023)
5.2 Americas Extracorporeal Circulation Supporting Intubation Sales by Type
5.3 Americas Extracorporeal Circulation Supporting Intubation Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Extracorporeal Circulation Supporting Intubation Sales by Region
6.1.1 APAC Extracorporeal Circulation Supporting Intubation Sales by Region (2018-2023)
6.1.2 APAC Extracorporeal Circulation Supporting Intubation Revenue by Region (2018-2023)
6.2 APAC Extracorporeal Circulation Supporting Intubation Sales by Type
6.3 APAC Extracorporeal Circulation Supporting Intubation Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Extracorporeal Circulation Supporting Intubation by Country
7.1.1 Europe Extracorporeal Circulation Supporting Intubation Sales by Country (2018-2023)
7.1.2 Europe Extracorporeal Circulation Supporting Intubation Revenue by Country (2018-2023)
7.2 Europe Extracorporeal Circulation Supporting Intubation Sales by Type
7.3 Europe Extracorporeal Circulation Supporting Intubation Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Extracorporeal Circulation Supporting Intubation by Country
8.1.1 Middle East & Africa Extracorporeal Circulation Supporting Intubation Sales by Country (2018-2023)
8.1.2 Middle East & Africa Extracorporeal Circulation Supporting Intubation Revenue by Country (2018-2023)
8.2 Middle East & Africa Extracorporeal Circulation Supporting Intubation Sales by Type
8.3 Middle East & Africa Extracorporeal Circulation Supporting Intubation Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Extracorporeal Circulation Supporting Intubation
10.3 Manufacturing Process Analysis of Extracorporeal Circulation Supporting Intubation
10.4 Industry Chain Structure of Extracorporeal Circulation Supporting Intubation
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Extracorporeal Circulation Supporting Intubation Distributors
11.3 Extracorporeal Circulation Supporting Intubation Customer
12 World Forecast Review for Extracorporeal Circulation Supporting Intubation by Geographic Region
12.1 Global Extracorporeal Circulation Supporting Intubation Market Size Forecast by Region
12.1.1 Global Extracorporeal Circulation Supporting Intubation Forecast by Region (2024-2029)
12.1.2 Global Extracorporeal Circulation Supporting Intubation Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Extracorporeal Circulation Supporting Intubation Forecast by Type
12.7 Global Extracorporeal Circulation Supporting Intubation Forecast by Application
13 Key Players Analysis
13.1 Changzhou Kangxin Medical Devices
13.1.1 Changzhou Kangxin Medical Devices Company Information
13.1.2 Changzhou Kangxin Medical Devices Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.1.3 Changzhou Kangxin Medical Devices Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Changzhou Kangxin Medical Devices Main Business Overview
13.1.5 Changzhou Kangxin Medical Devices Latest Developments
13.2 WEGO
13.2.1 WEGO Company Information
13.2.2 WEGO Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.2.3 WEGO Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 WEGO Main Business Overview
13.2.5 WEGO Latest Developments
13.3 Raumedic
13.3.1 Raumedic Company Information
13.3.2 Raumedic Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.3.3 Raumedic Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Raumedic Main Business Overview
13.3.5 Raumedic Latest Developments
13.4 Medtronic
13.4.1 Medtronic Company Information
13.4.2 Medtronic Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.4.3 Medtronic Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Medtronic Main Business Overview
13.4.5 Medtronic Latest Developments
13.5 Edward Lifescience
13.5.1 Edward Lifescience Company Information
13.5.2 Edward Lifescience Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.5.3 Edward Lifescience Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Edward Lifescience Main Business Overview
13.5.5 Edward Lifescience Latest Developments
13.6 LivaNova
13.6.1 LivaNova Company Information
13.6.2 LivaNova Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.6.3 LivaNova Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 LivaNova Main Business Overview
13.6.5 LivaNova Latest Developments
13.7 Surge Cardiovascular
13.7.1 Surge Cardiovascular Company Information
13.7.2 Surge Cardiovascular Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.7.3 Surge Cardiovascular Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Surge Cardiovascular Main Business Overview
13.7.5 Surge Cardiovascular Latest Developments
13.8 Chalice Medical
13.8.1 Chalice Medical Company Information
13.8.2 Chalice Medical Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.8.3 Chalice Medical Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Chalice Medical Main Business Overview
13.8.5 Chalice Medical Latest Developments
13.9 Xenios AG
13.9.1 Xenios AG Company Information
13.9.2 Xenios AG Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.9.3 Xenios AG Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Xenios AG Main Business Overview
13.9.5 Xenios AG Latest Developments
13.10 Getinge
13.10.1 Getinge Company Information
13.10.2 Getinge Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.10.3 Getinge Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Getinge Main Business Overview
13.10.5 Getinge Latest Developments
13.11 Beijing Medos
13.11.1 Beijing Medos Company Information
13.11.2 Beijing Medos Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.11.3 Beijing Medos Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Beijing Medos Main Business Overview
13.11.5 Beijing Medos Latest Developments
13.12 Kewei Medical
13.12.1 Kewei Medical Company Information
13.12.2 Kewei Medical Extracorporeal Circulation Supporting Intubation Product Portfolios and Specifications
13.12.3 Kewei Medical Extracorporeal Circulation Supporting Intubation Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Kewei Medical Main Business Overview
13.12.5 Kewei Medical Latest Developments
14 Research Findings and Conclusion
※参考情報 体外循環は、患者の体外で血液を循環させる技術であり、心肺機能が著しく低下している患者に対して行われます。これにより、心臓や肺の機能を補助し、必要な治療を行うための時間を稼ぐことができます。体外循環支持の一形態として、挿管をサポートする体外循環、つまりExtracorporeal Circulation Supporting Intubation(EC-Intubation)が存在します。この概念について、以下に詳細に説明します。 まず、EC-Intubationの定義ですが、これは重篤な呼吸不全や心不全の患者に対して、気道管理を安全に行うために体外循環装置を用いる技術です。この方法では、体外循環システムが血液中の酸素化を助け、二酸化炭素の排出を促進します。その結果、医療従事者は気道を確保する際に生じる急激な酸素飽和の低下を緩和することができ、挿管操作をより安全かつ効果的に行うことが可能になります。 次に、EC-Intubationの特徴について述べます。主な特徴の一つは、体外循環装置による血液の酸素化と循環の補助です。体外循環装置には、ポンプ、酸素化器、及び血液フィルターなどが含まれおり、これにより体内のデリケートな状況下でも患者の命を守ることが可能になります。また、EC-Intubationは緊急時だけでなく、手術中や手術後の患者においても使用されることがあります。さらに、体外循環は心臓や呼吸器系の負担を軽減するため、患者の状態が安定するまでの間、その支持を行う役割を果たします。 EC-Intubationにはいくつかの種類があります。一般的には、静脈-動脈ECMO(Extra Corporeal Membrane Oxygenation)が用いられます。この方式では、静脈から血液を体外に引き出し、酸素化した後に動脈に戻すというプロセスが行われます。また、静脈-静脈ECMOもあり、特に心肺機能が低下している場合に用いられます。これらの方法はいずれも、気道確保の際のリスクを軽減することを目的としています。 EC-Intubationの用途としては、重篤な呼吸不全や心不全、または大量の気道分泌物がある場合などが挙げられます。例えば、COVID-19やインフルエンザなどのウイルス感染による重症肺炎では、EC-Intubationが医療チームにとって重要な手段となり得ます。これにより、短時間での適切な気道管理が可能となり、患者の生存率を高めることが期待されます。 また、EC-Intubationは特定の手術においても有用です。特に、高リスクの外科手術や緊急手術の際には、体外循環が用いられることにより、安全な手技が保証されます。これにより、患者の状態が一時的に不安定になる場面でも、迅速に対応することが可能です。 関連技術としては、体外循環用の血液ポンプや膜酸素化器の発展があります。これらは、より効果的に血液を酸素化し、二酸化炭素を除去する能力を高めています。また、モニタリング機器の進化も重要です。患者の生理的指標や血液ガス分析をリアルタイムで行うことができるため、より正確な状態の把握と治療が可能となっています。 さらに、EC-Intubationは様々な配慮が必要な技術でもあります。体外循環装置を使用する際には、感染症予防や血液凝固管理に特に注意を払わなければなりません。装置を操作する医療従事者は、これらのリスクを理解し、適切な手順を遵守することが求められます。 総じて、EC-Intubationは、重篤な呼吸不全や心不全の患者において、挿管を安全に行うための重要な技術であると言えます。体外循環がもたらすサポートにより、医療従事者は緊急時にも冷静に対処でき、患者の生存率を高めることができます。今後も技術の進化が期待される分野であり、さらなる研究と発展が望まれます。医療現場では、EC-Intubationを含む高度な技術の理解と適切な運用が、患者の安全と健康を守るために不可欠です。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/